# Cancer medicine

Source: https://onco.cc/journals/cancer-medicine/  
OnCo record `cancer-medicine` (Journal). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Cancer Medicine is a large open-access Wiley journal, launched in 2012, that takes research from every part of oncology, from laboratory biology to clinical trials and prevention, and also accepts papers referred from other Wiley journals. All articles are CC BY, with an article processing charge.

## Summary

Cancer Medicine is a peer-reviewed, open access, interdisciplinary Wiley journal providing rapid publication of research across the cancer sciences. It considers submissions from all oncology specialties in four broad sections: clinical cancer research (trials, chemotherapy, radiation and surgical therapy, guidelines), cancer biology (molecular and cellular biology, genomics, immunology, epigenetics, carcinogenesis, drug discovery), cancer prevention (behavioural and psychosocial studies, screening, nutrition, epidemiology) and bioinformatics. Article types are original research, systematic reviews, meta-analyses, methods papers, brief communications and invited editorials and commentaries, and it also takes papers referred from other Wiley journals. All articles are published under the Creative Commons Attribution (CC BY) licence with authors retaining copyright; DOAJ records an article processing charge with waivers and anonymous peer review. Launched in 2012. Indexed in MEDLINE and deposited in PubMed Central.

## Fields

- Kind: Journal
- Last checked: 2026-09-10
- Also known as: Cancer Med; Cancer Medicine
- Publisher: Wiley
- Scope: clinical oncology
- Access: open-access

## Sources

- Homepage: https://onlinelibrary.wiley.com/journal/20457634
- NLM Catalog: https://www.ncbi.nlm.nih.gov/nlmcatalog/101595310
- DOAJ record: https://doaj.org/toc/2045-7634

## Connected records

- collections: [PubMed & Europe PMC](https://onco.cc/collections/pubmed-europepmc/)
- key papers: [Are 90% of deaths from cancer caused by metastases?](https://onco.cc/key-papers/paper-dillekas-cancer-med/), [Phase II study (KAMELEON) of single-agent T-DM1 in patients with HER2-positive advanced urothelial bladder cancer or pancreatic cancer/cholangiocarcinoma](https://onco.cc/key-papers/paper-luca-gianni-cancer-med-2023/), [Relmacabtagene autoleucel (relma-cel) CD19 CAR-T therapy for adults with heavily pretreated relapsed/refractory large B-cell lymphoma in China](https://onco.cc/key-papers/paper-ying-cancer-med/), [Reverse swing-M, phase 1 study of repurposing mebendazole in recurrent high-grade glioma](https://onco.cc/key-papers/paper-patil-mebendazole-glioma-phase-1-cancer-med-2020/), [Salmonella enterica serovar Typhi and gallbladder cancer: a case-control study and meta-analysis](https://onco.cc/key-papers/paper-koshiol-salmonella-typhi-gallbladder-cancer-cancer-med-2016/)
- people: [Antonio Cuneo](https://onco.cc/people/antonio-cuneo/), [Goh Boon Cher](https://onco.cc/people/goh-boon-cher/), [Ruben Mesa](https://onco.cc/people/ruben-mesa/)

---
JSON: https://onco.cc/api/v1/entities/cancer-medicine.json